Recombinant Human herpesvirus 8 type P protein(VMI2) (Active)
Recombinant Human herpesvirus 8 type P protein(VMI2) (Active)

Western blot analysis of beta actin in COS7, Jurkat, C6 and 3T3 lysates using beta actin antibody (1:5000 diluted).

Recombinant Human herpesvirus 8 type P protein(VMI2) (Active)
Cat:
GS12913
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
Type:
Protein
Alias:
Viral macrophage inflammatory protein II Short name:vMIP-II vMIP-1B
Expressed Host:
E.Coli
Species:
Human herpesvirus 8 type P (isolate GK18) (HHV-8) (Kaposi's sarcoma-associated herpesvirus)
Price:
  • Product details
Product Name
Recombinant Human herpesvirus 8 type P protein(VMI2) (Active)
Cat
GS12913
Expression Region
Uniorot ID:Q98157(24-93aa)
Alias
Viral macrophage inflammatory protein II Short name:vMIP-II vMIP-1B
Expressed Host
E.Coli
Species
Human herpesvirus 8 type P (isolate GK18) (HHV-8) (Kaposi's sarcoma-associated herpesvirus)
Tag
Tag-Free
Purity
>97% as determined by SDS-PAGE and HPLC.
Endotoxin
Less than 1.0 EU/µg as determined by LAL method.
Buffer
Lyophilized from a 0.2 µm filtered PBS, pH 7.4
Biological activity
Fully biologically active when compared to standard. The specific activity is determined by the inhibitory effect on monocyte migration response to human MIP-1 alpha using a concentration range of 1.0µg-10.0µg/ml of viral MIP-2 will inhibit 25ng/ml of human MIP-1 alpha.
Storage
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Type
Protein
Purposes
For research use only